Elon Musk’s brain-chip inches closer to reality as Neuralink gears up for first human trials

Elon Musk’s Neuralink is all set to start its first human-based trial of the brain-chip that will enable paralysis patients to control movements through their thoughts.

Neuralink, a brain-chip startup of the billionaire entrepreneur, has said that an independent review board has given approval to commence the recruitment for the first human trial of its brain implant for paralysis patients.

People who have been paralysed due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the recruitment. However, the number of enrollments of participants has not been revealed yet. This clinical trial can span approximately over six years. This will pave the way for an extensive understanding about the safety and efficacy of the implant.